Management Of Pleural Mesothelioma, Global Insights On New Clinical Practice Guideline For The Treatment Of Malignant Pleural Mesothelioma Iaslc

The full guideline for the investigation and management of malignant pleural mesothelioma is published in thorax1 the key features of the guideline are highlighted in a short article published to accompany the full guideline2 the following is a summary of the recommendations and good practice points.

Mike reimer lawyer winnipeg. Malignant pleural mesothelioma accounts for 80 90 of all mesothelioma diagnoses. Malignant pleural mesothelioma mpm is a rare but aggressive tumor originating from the pleural cavity with a strong link to previous asbestos exposure. Management of pleural mesothelioma 14 anish thomas and raffit hassan introduction malignant mesothelioma is an aggressive tumor that arises from the serosal surfaces of pleura pericardium peritoneum or the tunica vaginalis.

Pleural mesothelioma is a cancer of the lining of the lungs known as the pleura. Surgery in patients with disease confined to the pleural space is reasonable. The pleura is the most common primary site accounting for 80 to 90.

Through a record linkage betw. Current status of evidence on management. Symptoms of pleural mesothelioma include shortness of breath dry cough and chest pain.

The following is a summary of the recommendations and good practice points. Up to 3000 patients are affected annually in the united states. In order to determine the demographics diagnostics therapeutic strategies and prognosis of mpm patients in austria the austrian mesothelioma interest group amig was founded in 2011.

Treatment options for the management of malignant mesothelioma include surgery chemotherapy 2 3 radiation and multimodality treatment. The 2016 mesothelioma audit data reported that in the uk in 2014 pleural mesothelioma accounted for 2179 cases 97 with 70 peritoneal cases approximately 3. The focus of this guideline is mpm as it is far more common than mesothelioma occurring in the abdomen.

Surgery radiotherapy and chemotherapy are endlessly discussed often with limited scientific evidence to support strongly held. A definite consensus on its management has yet to be established. Malignant pleural mesothelioma mpm has caused and is still causing violent debate between protagonists and antagonists of the three options in relation to treatment.

The sections referred to in the summary refer to the full guideline. The full guideline for the investigation and management of malignant pleural mesothelioma is published in thorax. It is caused by inhaling asbestos fibers.

Pleural mesothelioma pm is a rare highly lethal tumor.